The conversion of the TME and sensitization of NB tumors to anti-PDL-1 mAb via Syk inhibition using fostamatinib, with anti-PDL1 mAb and radiation, work synergistically and appear to be a promising strategy for NB treatment [122]. This evidence concerns the gene SYK and neuroblastoma.